Literature DB >> 16422124

Awareness, treatment and control of the metabolic syndrome and its components: a multicentre Greek study.

Vasilios G Athyros1, Emmanuel S Ganotakis, Maria Bathianaki, Ioannis Monedas, Ioannis A Goudevenos, Athanasios A Papageorgiou, Athanasios Papathanasiou, Anna I Kakafika, Dimitri P Mikhailidis, Moses Elisaf.   

Abstract

INTRODUCTION: There are no data concerning the degree of awareness, treatment and control of the metabolic syndrome (MetS) and its components or associated vascular risk in the general population.
METHODS: A cross-sectional analysis was made of a representative sample of Greek adults (n=9669, 49% men and 51% women), living in urban, semi-urban and rural areas (55%, 23% and 22%, respectively). The National Cholesterol Education Program (NCEP-ATP III) and the International Diabetes Federation (IDF) definitions for the MetS were used.
RESULTS: The age-standardised prevalence of the MetS in the general population was 24.5% [95% CI 23.4-25.7%] (n=2369). This was similar in men and women and increased with age. Among subjects with the NCEP MetS the prevalence of hypertension was 71%, elevated blood glucose 55%, low high-density lipoprotein cholesterol 58%, high triglycerides 63% and abdominal obesity 82%. Only one third of subjects were aware of the MetS component conditions, less than one quarter were on treatment, and very few (< or =10%) were controlled for MetS components. Awareness of MetS individual component conditions (e.g. arterial hypertension), and consequently effective control, was lower than that reported in other cohorts, including subjects without MetS. Only 5% of subjects were aware of MetS as an entity, 2% were treated for all component conditions and only 1% were controlled. Using the IDF definition, the prevalence of MetS was higher (43.4%) and awareness, treatment and control of MetS and its components were significantly lower.
CONCLUSIONS: The prevalence of MetS is high in Greece but is not recognised among the general population. Therefore, treatment and control of MetS and component conditions are extremely low. If the situation does not improve soon, MetS will cause a further increase in the vascular disease epidemic in the years to come. This calls for urgent education of the public and the medical community.

Entities:  

Mesh:

Year:  2005        PMID: 16422124

Source DB:  PubMed          Journal:  Hellenic J Cardiol        ISSN: 1109-9666


  16 in total

1.  Rationale, design and baseline patient characteristics of the optimal type 2 diabetes management including benchmarking and standard treatment study in Greece.

Authors:  Michael S Kostapanos; Vasilis Tsimihodimos; Moses S Elisaf; Emmanouil Tzouvelekis; Nikos Nikas
Journal:  World J Diabetes       Date:  2014-02-15

2.  Prevalence of Metabolic Syndrome and Affecting Factors among Individuals Aged 30 and over in Balçova District of İzmir.

Authors:  Ahmet Soysal; Hatice Şimşek; Sinem Doğanay; Türkan Günay
Journal:  Balkan Med J       Date:  2016-05-01       Impact factor: 2.021

3.  Combination drug treatment in obese diabetic patients.

Authors:  Theodosios D Filippatos; Moses S Elisaf
Journal:  World J Diabetes       Date:  2010-03-15

4.  Diverging trends in cardiovascular morbidity and mortality in a low risk population.

Authors:  Theodore Chimonas; Irene Fanouraki; Evangelos N Liberopoulos; Elias Chimonas; Moses Elisaf
Journal:  Eur J Epidemiol       Date:  2009-06-17       Impact factor: 8.082

5.  National Cholesterol Educational Program and International Diabetes Federation diagnostic criteria for metabolic syndrome in an Italian cohort: results from the FIBAR Study.

Authors:  E Mannucci; M Monami; G Bardini; A Ognibene; C M Rotella
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

6.  Self-reported prevalence of atherothrombosis in a general population sample of adults in Greece; a telephone survey.

Authors:  Nikos Maniadakis; Georgia Kourlaba; Vasileios Fragoulakis
Journal:  BMC Cardiovasc Disord       Date:  2011-04-14       Impact factor: 2.298

7.  Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional study.

Authors:  Milos Z Maksimovic; Hristina D Vlajinac; Djordje J Radak; Jelena M Marinkovic; Jagoda B Jorga
Journal:  BMC Cardiovasc Disord       Date:  2012-01-31       Impact factor: 2.298

8.  Economic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece.

Authors:  Vassilis Fragoulakis; Georgia Kourlaba; Nikolaos Maniadakis
Journal:  Clinicoecon Outcomes Res       Date:  2012-05-29

9.  Implementation of guidelines for the management of arterial hypertension. The impulsion study.

Authors:  Asterios Karagiannis; Apostolos I Hatzitolios; Vasilios G Athyros; Kalliopi Deligianni; Charalambos Charalambous; Christos Papathanakis; Georgios Theodosiou; Theodoros Drakidis; Veronika Chatzikaloudi; Chysanthi Kamilali; Sotirios Matsiras; Athanasios Matziris; Christos Savopoulos; Maria Baltatzi; Jobst Rudolf; Konstantinos Tziomalos; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2009-05-05

10.  Prevalence of the metabolic syndrome in a rural population in Ghana.

Authors:  Mawuli Gyakobo; Albert Gb Amoah; De-Anne Martey-Marbell; Rachel C Snow
Journal:  BMC Endocr Disord       Date:  2012-10-30       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.